Innovations Enable Packaging to Play Many Roles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovations Enable Packaging to Play Many Roles
Drug packaging performs functions such as ensuring patient well-being, providing information, preventing tampering, blocking counterfeiting, and improving compliance. Since 1977, packaging innovations have occurred in four major categories. The author provides an overview of major packaging improvements that have emerged in the past 30 years.


Pharmaceutical Technology


Development must continue on all fronts, however. Despite our best efforts, fewer than 50% of prescriptions are taken correctly, tens of thousands of medication errors occur each year, an estimated 10% of all drug products worldwide are counterfeit, and quality-control lapses serious enough to warrant a recall put consumers in jeopardy on a monthly, if not weekly basis.

Hallie Forcinio is Pharmaceutical Technology's "Packaging Forum" editor, 4708 Morningside Dr., Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,

Where were you 30 years ago?

"I was working as a marketing communications assistant at an engineering and construction firm, living in my first apartment, and looking for a new job. I found a new job that led me to meet some nice people, including the man I eventually married, but was otherwise mostly awful. I spent my spare time editing a biannual newsletter for the Kappa Phi Club, an organization for Christian collegiate women."

References

1. Consumer Product Safety Commission, "Child Resistant Packaging Saves Lives," CPSC Document #5019, http://www.cpsc.gov/cpscpub/pubs/5019.html (accessed June 7, 2007).

2. CPSC, "Use Child-Resistant Containers," CPSC Document #5018, http://www.cpsc.gov/cpscpub/pubs/5018.html (accessed June 7, 2007).

3. US Food and Drug Administration, Prescription Drug Marketing Act—Pedigree Requirements under 21 CFR Part 203, Draft Compliance Policy Guide 160.900 (Rockville, MD, June 2006).

4. Hallie Forcinio, "Bar Coding Deadline Looms," Pharm. Technol. 29 (5), 42–46 (2005).

5. Holly Wagner, "One-on-One with Pharmacists Gives Patients Medication Advantage," Research News (Ohio State University, Columbus, OH), researchnews.osu.edu/archive/chudrug.htm (accessed June 7, 2007).

6. Hallie Forcinio, "Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers," Pharm. Technol. 27 (9), 38–45 (2003).

7. Hallie Forcinio, "Interphex Showcases Packaging Innovations," Pharm. Technol. 31 (6), 42–47 (2007).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here